X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Biocon Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs BIOCON - Comparison Results

BIOCON  
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE BIOCON TTK HEALTHCARE/
BIOCON
 
P/E (TTM) x 19.3 41.0 47.1% View Chart
P/BV x 2.3 7.1 31.9% View Chart
Dividend Yield % 0.7 0.2 451.1%  

Financials

 TTK HEALTHCARE   BIOCON
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-18
BIOCON
Mar-18
TTK HEALTHCARE/
BIOCON
5-Yr Chart
Click to enlarge
High Rs1,4581,188 122.7%   
Low Rs795305 260.7%   
Sales per share (Unadj.) Rs408.768.7 594.8%  
Earnings per share (Unadj.) Rs12.97.6 170.3%  
Cash flow per share (Unadj.) Rs23.614.0 169.3%  
Dividends per share (Unadj.) Rs5.001.00 500.0%  
Dividend yield (eoy) %0.40.1 331.4%  
Book value per share (Unadj.) Rs164.986.3 190.9%  
Shares outstanding (eoy) m14.13600.00 2.4%   
Bonus/Rights/Conversions ISIS-  
Price / Sales ratio x2.810.9 25.4%   
Avg P/E ratio x87.698.9 88.6%  
P/CF ratio (eoy) x47.653.4 89.2%  
Price / Book Value ratio x6.88.6 79.0%  
Dividend payout %38.913.2 293.6%   
Avg Mkt Cap Rs m15,916447,900 3.6%   
No. of employees `0002.26.1 36.5%   
Total wages/salary Rs m1,0909,311 11.7%   
Avg. sales/employee Rs Th2,573.86,705.8 38.4%   
Avg. wages/employee Rs Th485.71,514.2 32.1%   
Avg. net profit/employee Rs Th81.0736.9 11.0%   
INCOME DATA
Net Sales Rs m5,77641,234 14.0%  
Other income Rs m762,062 3.7%   
Total revenues Rs m5,85143,296 13.5%   
Gross profit Rs m4268,291 5.1%  
Depreciation Rs m1523,851 4.0%   
Interest Rs m47615 7.7%   
Profit before tax Rs m3025,887 5.1%   
Minority Interest Rs m0213 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1201,569 7.6%   
Profit after tax Rs m1824,531 4.0%  
Gross profit margin %7.420.1 36.6%  
Effective tax rate %39.726.7 149.1%   
Net profit margin %3.111.0 28.6%  
BALANCE SHEET DATA
Current assets Rs m2,55641,486 6.2%   
Current liabilities Rs m1,67521,413 7.8%   
Net working cap to sales %15.348.7 31.3%  
Current ratio x1.51.9 78.8%  
Inventory Days Days3364 52.3%  
Debtors Days Days3594 37.1%  
Net fixed assets Rs m1,10350,661 2.2%   
Share capital Rs m1413,000 4.7%   
"Free" reserves Rs m2,18848,808 4.5%   
Net worth Rs m2,33051,808 4.5%   
Long term debt Rs m717,898 0.0%   
Total assets Rs m4,07399,897 4.1%  
Interest coverage x7.410.6 69.7%   
Debt to equity ratio x00.3 0.8%  
Sales to assets ratio x1.40.4 343.5%   
Return on assets %5.65.2 109.1%  
Return on equity %7.88.7 89.2%  
Return on capital %14.99.6 155.0%  
Exports to sales %3.00-   
Imports to sales %0.60-   
Exports (fob) Rs m172NA-   
Imports (cif) Rs m35NA-   
Fx inflow Rs m17212,058 1.4%   
Fx outflow Rs m557,348 0.8%   
Net fx Rs m1174,710 2.5%   
CASH FLOW
From Operations Rs m2536,621 3.8%  
From Investments Rs m-226-6,840 3.3%  
From Financial Activity Rs m-72-2,397 3.0%  
Net Cashflow Rs m-41-2,612 1.6%  

Share Holding

Indian Promoters % 65.4 40.4 161.9%  
Foreign collaborators % 0.0 20.6 -  
Indian inst/Mut Fund % 3.7 8.4 44.0%  
FIIs % 5.2 10.7 48.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 19.9 129.6%  
Shareholders   12,723 109,995 11.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   JUBILANT LIFE SCIENCES  DR. DATSONS LABS  CADILA HEALTHCARE  GSK PHARMA  PANACEA BIOTECH  

Compare TTK HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Market Drivers, Key Q4FY19 Results and Aviation Stocks in Focus(Pre-Open)

Market participants will track Tata Coffee, HDFC Bank, Mahindra Life, Tejas Networks, AU Small Finance Bank among others as they announce their March quarter results today.

Related Views on News

TTK HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

BIOCON LTD Announces Quarterly Results (3QFY19); Net Profit Up 169.2% (Quarterly Result Update)

Jan 28, 2019 | Updated on Jan 28, 2019

For the quarter ended December 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 169.2% YoY). Sales on the other hand came in at Rs 15 bn (up 45.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 15.3% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, TTK HEALTHCARE has posted a net profit of Rs 67 m (down 15.3% YoY). Sales on the other hand came in at Rs 2 bn (up 16.3% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

BIOCON LTD Announces Quarterly Results (2QFY19); Net Profit Up 501.9% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, BIOCON LTD has posted a net profit of Rs 4 bn (up 501.9% YoY). Sales on the other hand came in at Rs 13 bn (up 36.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

More Views on News

Most Popular

Stocks that Could Be Out of Reach Post Elections(The 5 Minute Wrapup)

Apr 9, 2019

It's a matter of time before the stocks catch the fancy of the markets and big investors.

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Apr 18, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 8-QTR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS